Dr. Bornhorst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E Chicago Ave
# 30
Chicago, IL 60611Phone+1 312-227-4090
Education & Training
- Children's National Medical Center/George Washington UniversityFellowship, Pediatric Neuro-Oncology, 2014 - 2015
- University of MichiganFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- University of MichiganResidency, Pediatrics, 2008 - 2011
- Creighton University School of MedicineClass of 2008
Certifications & Licensure
- MI State Medical License 2008 - 2027
- IL State Medical License 2023 - 2026
- DC State Medical License 2014 - 2024
- MD State Medical License 2022 - 2024
- VA State Medical License 2021 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1
- Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 Start of enrollment: 2018 Jul 12
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
- Join now to see all
Publications & Presentations
PubMed
- 19 citationsLong-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.Andrea M Gross, Eva Dombi, Pamela L Wolters, Andrea Baldwin, Anne Dufek
Neuro-Oncology. 2023-10-03 - 8 citationsThe Brain Tumor Segmentation (BraTS) Challenge 2023:.Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Debanjan Haldar, Zhifan Jiang
Arxiv. 2024-05-23 - 158 citationsSelumetinib in Children with Inoperable Plexiform NeurofibromasAndrea M. Gross, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb
The New England Journal of Medicine. 2020-03-18
Press Mentions
- Lurie Children’s Developing Optical Genome Mapping Test for Brain TumorsNovember 8th, 2024
- Lurie Children’s to Develop a Novel Genomic Test for More Rapid Precision Diagnosis of Brain TumorsNovember 4th, 2024
- Biden Cancer Moonshot Initiative Awards over $6 Million to 11 Early-Career Researchers for Innovative Cancer ResearchNovember 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: